{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:44:58Z","timestamp":1790516698422,"version":"4.1.0"},"reference-count":99,"publisher":"Baishideng Publishing Group Inc.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJT"],"published-print":{"date-parts":[[2016]]},"DOI":"10.5500\/wjt.v6.i3.505","type":"journal-article","created":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T10:16:36Z","timestamp":1474625796000},"page":"505","source":"Crossref","is-referenced-by-count":68,"title":["Recent insights in the pathogenesis of post-transplantation lymphoproliferative disorders"],"prefix":"10.5500","volume":"6","author":[{"given":"Julie","family":"Morscio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Tousseyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(64)91524-7"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200008173430707"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.88"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-196809000-00010"},{"key":"ref5","unstructured":"Swerldow S, Webber SA, Chadburn A, Ferry JA. Post-transplant lymphoproliferative disorders. WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues Lyon: IARC; 2008;343-349."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26001"},{"key":"ref7","unstructured":"Akar Özkan E, Özdemir BH, Akdur A, Deniz EE, Haberal M. Burkitt lymphoma after transplant: an aggressive lymphoproliferative disease. Exp Clin Transplant 2014;12 Suppl 1:136-138."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2007.02870.x"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3046.2008.01026.x"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-05-615872"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2015.12.008"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Thorley-Lawson DA. EBV the prototypical human tumor virus--just how bad is it? J Allergy Clin Immunol 2005;116:251-261; quiz 262.","DOI":"10.1016\/j.jaci.2005.05.038"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-10-567479"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Gong JZ, Stenzel TT, Bennett ER, Lagoo AS, Dunphy CH, Moore JO, Rizzieri DA, Tepperberg JH, Papenhausen P, Buckley PJ. Burkitt lymphoma arising in organ transplant recipients: a clinicopathologic study of five cases. Am J Surg Pathol 2003;27:818-827.","DOI":"10.1097\/00000478-200306000-00014"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0020023"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-230X(10)07004-1"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2015.09.007"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2016.03.008"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.2.1296-1307.2005"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Miller G, El-Guindy A, Countryman J, Ye J, Gradoville L. Lytic cycle switches of oncogenic human gammaherpesviruses. Adv Cancer Res 2007;97:81-109.","DOI":"10.1016\/S0065-230X(06)97004-3"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01574-15"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Jones RJ, Seaman WT, Feng WH, Barlow E, Dickerson S, Delecluse HJ, Kenney SC. Roles of lytic viral infection and IL-6 in early versus late passage lymphoblastoid cell lines and EBV-associated lymphoproliferative disease. Int J Cancer 2007;121:1274-1281.","DOI":"10.1002\/ijc.22839"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01512-10"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.22.13993-14003.2005"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.23911"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/hon.859"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2014.68"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/35000501"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/hon.751"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1545"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3109\/0284186X.2013.844853"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Craig FE, Johnson LR, Harvey SA, Nalesnik MA, Luo JH, Bhattacharya SD, Swerdlow SH. Gene expression profiling of Epstein-Barr virus-positive and -negative monomorphic B-cell posttransplant lymphoproliferative disorders. Diagn Mol Pathol 2007;16:158-168.","DOI":"10.1097\/PDM.0b013e31804f54a9"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/cas.12389"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1683"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200323765"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12271-4"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20287"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000163288.98419.0D"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08125.x"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13558"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.22249"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0804295105"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Cerri M, Capello D, Muti G, Rambaldi A, Paulli M, Gloghini A, Berra E, Deambrogi C, Rossi D, Franceschetti S. Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders. Br J Haematol 2004;127:362-364.","DOI":"10.1111\/j.1365-2141.2004.05203.x"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0400945101"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.231326898"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.213"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12196"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00541-13"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-11-320481"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003341"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1411087"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13324"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Shimizu N, Tanabe-Tochikura A, Kuroiwa Y, Takada K. Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt’s lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV. J Virol 1994;68:6069-6073.","DOI":"10.1128\/JVI.68.9.6069-6073.1994"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1309\/AJCP2G0VKTKPNPRR"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Gallagher A, Perry J, Freeland J, Alexander FE, Carman WF, Shield L, Cartwright R, Jarrett RF. Hodgkin lymphoma and Epstein-Barr virus (EBV): no evidence to support hit-and-run mechanism in cases classified as non-EBV-associated. Int J Cancer 2003;104:624-630.","DOI":"10.1002\/ijc.10979"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1309\/AJCP2T4IIIZKBHMI"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Theate I, Michaux L, Squifflet JP, Martin A, Raphael M. Human herpesvirus 8 and Epstein-Barr virus-related monotypic large B-cell lymphoproliferative disorder coexisting with mixed variant of Castleman’s disease in a lymph node of a renal transplant recipient. Clin Transplant 2003;17:451-454.","DOI":"10.1034\/j.1399-0012.2003.00098.x"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.12172"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-11-599951"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Leblond V, Davi F, Charlotte F, Dorent R, Bitker MO, Sutton L, Gandjbakhch I, Binet JL, Raphael M. Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity? J Clin Oncol 1998;16:2052-2059.","DOI":"10.1200\/JCO.1998.16.6.2052"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Nelson BP, Nalesnik MA, Bahler DW, Locker J, Fung JJ, Swerdlow SH. Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity? Am J Surg Pathol 2000;24:375-385.","DOI":"10.1097\/00000478-200003000-00006"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-01-553412"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01069-12"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.9881"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2012.03.025"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.3109\/10428190903315713"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20087"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-03-488171"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201141832"},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"Vinay DS, Ryan EP, Pawelec G, Talib WH, Stagg J, Elkord E, Lichtor T, Decker WK, Whelan RL, Kumara HM. Immune evasion in cancer: Mechanistic basis and therapeutic strategies. Semin Cancer Biol 2015;35 Suppl:S185-S198.","DOI":"10.1016\/j.semcancer.2015.03.004"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0855"},{"key":"ref73","doi-asserted-by":"crossref","unstructured":"Toscano MA, Bianco GA, Ilarregui JM, Croci DO, Correale J, Hernandez JD, Zwirner NW, Poirier F, Riley EM, Baum LG. Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat Immunol 2007;8:825-834.","DOI":"10.1038\/ni1482"},{"key":"ref74","doi-asserted-by":"crossref","unstructured":"Barros MH, Hassan R, Niedobitek G. Tumor-associated macrophages in pediatric classical Hodgkin lymphoma: association with Epstein-Barr virus, lymphocyte subsets, and prognostic impact. Clin Cancer Res 2012;18:3762-3771.","DOI":"10.1158\/1078-0432.CCR-12-0129"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1937"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.12703\/P6-13"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2011.01282.x"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-04-421057"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2015"},{"key":"ref80","doi-asserted-by":"crossref","unstructured":"Bellan C, Lazzi S, Hummel M, Palummo N, de Santi M, Amato T, Nyagol J, Sabattini E, Lazure T, Pileri SA. Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. Blood 2005;106:1031-1036.","DOI":"10.1182\/blood-2005-01-0168"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1002\/path.2410"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-06-507996"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergen.2015.12.005"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-301556"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1038\/nm758"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19961009)68:2<251::AID-IJC19>3.0.CO;2-D"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22372"},{"key":"ref88","doi-asserted-by":"crossref","unstructured":"Delecluse HJ, Anagnostopoulos I, Dallenbach F, Hummel M, Marafioti T, Schneider U, Huhn D, Schmidt-Westhausen A, Reichart PA, Gross U. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 1997;89:1413-1420.","DOI":"10.1182\/blood.V89.4.1413"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000470"},{"key":"ref90","doi-asserted-by":"crossref","unstructured":"Gaidano G, Cerri M, Capello D, Berra E, Deambrogi C, Rossi D, Larocca LM, Campo E, Gloghini A, Tirelli U. Molecular histogenesis of plasmablastic lymphoma of the oral cavity. Br J Haematol 2002;119:622-628.","DOI":"10.1046\/j.1365-2141.2002.03872.x"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2011.06.506"},{"key":"ref92","doi-asserted-by":"crossref","unstructured":"Vega F, Chang CC, Medeiros LJ, Udden MM, Cho-Vega JH, Lau CC, Finch CJ, Vilchez RA, McGregor D, Jorgensen JL. Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles. Mod Pathol 2005;18:806-815.","DOI":"10.1038\/modpathol.3800355"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-2-47"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.109"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000234"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-015-0053-0"},{"key":"ref97","doi-asserted-by":"crossref","unstructured":"Fernandez-Alvarez R, Gonzalez-Rodriguez AP, Rubio-Castro A, Gonzalez ME, Payer AR, Alonso-Garcia A, Rodriguez-Villar D, Dominguez-Iglesias F, Sancho JM. Bortezomib plus CHOP for the treatment of HIV-associated plasmablastic lymphoma: clinical experience in three patients. Leuk Lymphoma 2015; Jun 18; Epub ahead of print.","DOI":"10.3109\/10428194.2015.1050666"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.08.017"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.141978"}],"container-title":["World Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/2220-3230\/full\/v6\/i3\/505.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T06:38:46Z","timestamp":1601102326000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/2220-3230\/full\/v6\/i3\/505.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":99,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.5500\/wjt.v6.i3.505","relation":{},"ISSN":["2220-3230"],"issn-type":[{"value":"2220-3230","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}